Hong Qi

816 total citations
29 papers, 597 citations indexed

About

Hong Qi is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Hong Qi has authored 29 papers receiving a total of 597 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 14 papers in Cancer Research and 8 papers in Oncology. Recurrent topics in Hong Qi's work include Cancer-related molecular mechanisms research (6 papers), RNA modifications and cancer (5 papers) and MicroRNA in disease regulation (3 papers). Hong Qi is often cited by papers focused on Cancer-related molecular mechanisms research (6 papers), RNA modifications and cancer (5 papers) and MicroRNA in disease regulation (3 papers). Hong Qi collaborates with scholars based in China, Taiwan and Germany. Hong Qi's co-authors include Yang Liu, Zhi‐Ming Shao, Yu Yang, Xiulan Zhao, Gen‐Hong Di, Guang‐Yu Liu, Baocun Sun, Xueyi Dong, Run-Fen Cheng and Xia-Ying Kuang and has published in prestigious journals such as PLoS ONE, Bioresource Technology and Cell Death and Differentiation.

In The Last Decade

Hong Qi

28 papers receiving 594 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hong Qi China 17 430 198 125 61 61 29 597
Junyi Ju China 12 441 1.0× 217 1.1× 95 0.8× 72 1.2× 74 1.2× 15 578
Daniel Delgado‐Bellido Spain 10 339 0.8× 182 0.9× 175 1.4× 60 1.0× 56 0.9× 18 488
M. Ángeles Villaronga Spain 17 420 1.0× 162 0.8× 139 1.1× 74 1.2× 41 0.7× 28 577
Amar Desai United States 11 386 0.9× 157 0.8× 185 1.5× 52 0.9× 76 1.2× 23 599
Manabu Iyoda Japan 13 358 0.8× 143 0.7× 110 0.9× 48 0.8× 46 0.8× 28 462
Weiyu Ge China 9 324 0.8× 181 0.9× 173 1.4× 64 1.0× 79 1.3× 20 502
Jianbing Hou China 13 408 0.9× 148 0.7× 154 1.2× 51 0.8× 60 1.0× 24 629
Valery Adorno-Cruz United States 6 324 0.8× 205 1.0× 208 1.7× 59 1.0× 45 0.7× 6 513

Countries citing papers authored by Hong Qi

Since Specialization
Citations

This map shows the geographic impact of Hong Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong Qi more than expected).

Fields of papers citing papers by Hong Qi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hong Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong Qi. The network helps show where Hong Qi may publish in the future.

Co-authorship network of co-authors of Hong Qi

This figure shows the co-authorship network connecting the top 25 collaborators of Hong Qi. A scholar is included among the top collaborators of Hong Qi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hong Qi. Hong Qi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Guang‐Yu, et al.. (2025). FOXQ1 Suppressing Apoptosis in Colorectal Cancer Cells by P53 Deacetylation. Journal of College of Physicians And Surgeons Pakistan. 35(6). 722–729.
2.
Guo, Liang, Lei Xie, Bin Zhao, et al.. (2024). LncRNA MIAT binding to GATA3 activates MAPK signaling pathway and influences bronchopulmonary dysplasia. International Journal of Biological Macromolecules. 286. 138280–138280. 1 indexed citations
3.
Qu, Yu-jin, Jin-li Bai, Hong Qi, et al.. (2024). Variants located in intron 6 of SMN1 lead to misdiagnosis in genetic detection and screening for SMA. Heliyon. 10(6). e28015–e28015. 1 indexed citations
4.
Li, Jing, Tao Yang, Qihong Wang, et al.. (2022). Upregulation of SQLE Contributes to Poor Survival in Head and Neck Squamous Cell Carcinoma. International Journal of Biological Sciences. 18(9). 3576–3591. 21 indexed citations
5.
Xu, Chuanbo, Haitao Yu, Xianghua Yin, et al.. (2021). Circular RNA circNINL promotes breast cancer progression through activating β-catenin signaling via miR-921/ADAM9 axis. The Journal of Biochemistry. 169(6). 693–700. 6 indexed citations
6.
Hussain, Muhammad Hammad, Hong Qi, Waqas Qamar Zaman, et al.. (2021). Rationally optimized generation of integrated Escherichia coli with stable and high yield lycopene biosynthesis from heterologous mevalonate (MVA) and lycopene expression pathways. Synthetic and Systems Biotechnology. 6(2). 85–94. 29 indexed citations
7.
8.
Zhang, Ye, Qin Lu, Lin Zhang, et al.. (2019). RNF144A functions as a tumor suppressor in breast cancer through ubiquitin ligase activity-dependent regulation of stability and oncogenic functions of HSPA2. Cell Death and Differentiation. 27(3). 1105–1118. 41 indexed citations
9.
Meng, Haining, Junyu Wu, Qiao Huang, et al.. (2019). NEDD9 promotes invasion and migration of colorectal cancer cell line HCT116 via JNK/EMT. Oncology Letters. 18(4). 4022–4029. 21 indexed citations
10.
Zhang, Huaping, et al.. (2018). Transcriptome profiling analysis reveals biomarkers in colon cancer samples of various differentiation. Oncology Letters. 16(1). 48–54. 8 indexed citations
11.
Liu, Yang, et al.. (2018). MicroRNA-200a confers chemoresistance by antagonizing TP53INP1 and YAP1 in human breast cancer. BMC Cancer. 18(1). 74–74. 51 indexed citations
12.
Cai, Hong, et al.. (2017). CXCR6 predicts poor prognosis in gastric cancer and promotes tumor metastasis through epithelial-mesenchymal transition. Oncology Reports. 37(6). 3279–3286. 22 indexed citations
13.
14.
Jia, Xiaoqing, Hong Qi, Jingyi Cheng, et al.. (2015). Indispensability of Chemotherapy in Estrogen Receptor–Negative Early Breast Cancer in Elderly Women with Diabetes Mellitus. Diabetes Technology & Therapeutics. 17(4). 248–254. 1 indexed citations
15.
Liu, Yang, et al.. (2015). Reduced Expression of TET1, TET2, TET3 and TDG mRNAs Are Associated with Poor Prognosis of Patients with Early Breast Cancer. PLoS ONE. 10(7). e0133896–e0133896. 67 indexed citations
16.
Jia, Xiaoqing, Guang‐Yu Liu, Hong Qi, et al.. (2015). Accumulation of p53 is prognostic for aromatase inhibitor resistance in early-stage postmenopausal patients with ER-positive breast cancer. OncoTargets and Therapy. 8. 549–549. 3 indexed citations
17.
Qi, Hong, Baocun Sun, Xiulan Zhao, et al.. (2014). Wnt5a promotes vasculogenic mimicry and epithelial-mesenchymal transition via protein kinase Cα in epithelial ovarian cancer. Oncology Reports. 32(2). 771–779. 55 indexed citations
18.
Qi, Hong, et al.. (2013). Haemangiopericytoma of the jaw. Journal of Cranio-Maxillofacial Surgery. 42(5). 689–694. 5 indexed citations
19.
Qi, Hong, et al.. (2013). Effect of corona electric field on the production of gamma-poly glutamic acid based on bacillus natto. Journal of Physics Conference Series. 418. 12139–12139. 2 indexed citations
20.
Sun, Tao, Baocun Sun, Xiulan Zhao, et al.. (2008). Pilot study on the interaction between B16 melanoma cell-line and bone-marrow derived mesenchymal stem cells. Cancer Letters. 263(1). 35–43. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Junyi Ju Breakdown of academic impact, for papers by Daniel Delgado‐Bellido Breakdown of academic impact, for papers by M. Ángeles Villaronga Breakdown of academic impact, for papers by Amar Desai Breakdown of academic impact, for papers by Manabu Iyoda Breakdown of academic impact, for papers by Weiyu Ge Breakdown of academic impact, for papers by Jianbing Hou Breakdown of academic impact, for papers by Valery Adorno-Cruz
Rankless by CCL
2026